These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25531772)

  • 1. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
    Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
    Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ertapenem clearance during modeled continuous renal replacement therapy.
    Stevenson JM; Patel JH; Churchwell MD; Vilay AM; Depestel DD; Sörgel F; Kinzig M; Jakob V; Mueller BA
    Int J Artif Organs; 2008 Dec; 31(12):1027-34. PubMed ID: 19115194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iohexol transmembrane clearance during modeled continuous renal replacement therapy.
    Yardman-Frank JM; Mercier RC; Wong CS; Vilay AM
    Blood Purif; 2015; 39(1-3):188-192. PubMed ID: 25765443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations.
    Clajus C; Kühn-Velten WN; Schmidt JJ; Lorenzen JM; Pietsch D; Beutel G; Kielstein JT
    BMC Pharmacol Toxicol; 2013 Apr; 14():19. PubMed ID: 23551893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.
    Patel JH; Churchwell MD; Seroogy JD; Barriere SL; Grio M; Mueller B
    Int J Artif Organs; 2009 Oct; 32(10):745-51. PubMed ID: 19943236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.
    Lewis SJ; Switaj LA; Mueller BA
    Blood Purif; 2015; 40(1):66-71. PubMed ID: 26138225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary
    le Noble JLML; Foudraine N; van der Elst KCM; Bouwman S
    Int J Clin Pharmacol Ther; 2023 Nov; 61(11):525-530. PubMed ID: 37489071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
    Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
    J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
    Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.
    Pasko DA; Churchwell MD; Salama NN; Mueller BA
    Blood Purif; 2011; 32(2):82-8. PubMed ID: 21372565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
    Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
    J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Sánchez-Izquierdo JA; Pedraz JL
    Chemotherapy; 2007; 53(3):194-201. PubMed ID: 17356270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children.
    Thompson EJ; Wu H; Maharaj A; Edginton AN; Balevic SJ; Cobbaert M; Cunningham AP; Hornik CP; Cohen-Wolkowiez M
    Clin Pharmacokinet; 2019 Jul; 58(7):887-898. PubMed ID: 30840200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.
    Andrews L; Benken S; Tan X; Wenzler E
    BMC Nephrol; 2021 Jan; 22(1):45. PubMed ID: 33516188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.
    Pressiat C; Mea-Assande V; Yonaba C; Treluyer JM; Dahourou DL; Amorissani-Folquet M; Blanche S; Eboua F; Ye D; Lui G; Malateste K; Zheng Y; Leroy V; Hirt D;
    Br J Clin Pharmacol; 2017 Dec; 83(12):2729-2740. PubMed ID: 28800382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.